# Observational liver cancer studies recruiting: 100 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 100 trials that are observational for liver cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational liver cancer studies: 100 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/liver-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 100
- Recruiting or not yet: 100
- Read on: November 19, 2026

## Trials

The 25 newest of 100, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 13, 2026 | NCT07937137 | Liver Tumor Microenvironment Remodeling Promotes Hepatocellular Carcinoma Progression | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Observational | Not yet recruiting | Liver Cancer (Primary and Metastatic) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937137) |
| November 2, 2026 | NCT07911267 | Development and Utilization of an Integrated Clinical Genomic Database | Samsung Medical Center | Observational | Recruiting | Gastric Cancer, Colorectal Cancer, Lung Cancer (NSCLC), Liver Cancer, Pancreatic Cancer | 118,750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911267) |
| October 29, 2026 | NCT07904494 | Immune-Related Adverse Events and Clinical Outcomes of First-Line Immunotherapy in Egyptian Patients With Unresectable Hepatocellular... | Assiut University | Observational | Not yet recruiting | Hepatocellular Carcinoma, Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Non-Resectable, Hepatocellular... | 294 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904494) |
| October 28, 2026 | NCT07900984 | A Retrospective Registry of Intelliblate DUAL Channel Microwave Ablation | Varian, a Siemens Healthineers Company | Observational | Not yet recruiting | Liver Ablation, Liver Cancer, Liver Cancer (Primary and Metastatic) | 63 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900984) |
| October 5, 2026 | NCT07857317 | Non-Contrast Versus Contrast-Enhanced MRI in Colorectal Liver Metastases | Assiut University | Observational | Not yet recruiting | Liver Metastases, Liver Neoplasms | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07857317) |
| September 30, 2026 | NCT07848750 | InstaSure™ Non-Invasive Finger-Press Test for Hepatocellular Carcinoma | Beijing Municipal Administration of Hospitals | Observational | Recruiting | Hepatocellular Carcinoma | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07848750) |
| September 22, 2026 | NCT07834125 | Patients With Cryptogenic Hypertransaminasemia | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Cryptogenic Hypertransaminasemia | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07834125) |
| September 22, 2026 | NCT07832617 | Protoacoustic Imaging For 3D Mapping | University of Oklahoma | Observational | Recruiting | Proton Therapy, Radiation Therapy, Secondary Skin Reactions, Liver Cancer, Prostate Cancer | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07832617) |
| September 21, 2026 | NCT07830576 | Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation | Anhui Provincial Hospital | Observational | Recruiting | Colorectal Liver Metastases, Colorectal Neoplasms, Liver Neoplasms | 205 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07830576) |
| September 15, 2026 | NCT07820644 | A Cohort Study (Risk Prediction of HCC in Patients With Chronic Liver Disease) | Sponsor not shown (see the record) | Observational | Recruiting | Liver Cancer (Primary and Metastatic) | 15,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07820644) |
| August 14, 2026 | NCT07764835 | Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC) | D'Or Institute for Research and Education | Observational | Not yet recruiting | Hepatocellular Carcinoma, Liver Cirrhosis, Chronic Hepatitis B, Metabolic Dysfunction-Associated Steatotic Liver... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07764835) |
| August 3, 2026 | NCT07741903 | Development of a Risk Prediction Model for Immune-Targeted Therapy-Related Diarrhea in Patients With Hepatocellular Carcinoma Based on TCM... | Affiliated Hospital of Chengde Medical University | Observational | Not yet recruiting | Liver Cancer | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07741903) |
| July 27, 2026 | NCT07727759 | CT Volumetry and Hepatic Vascular Deformation Mapping to Predict Post-Hepatectomy Liver Failure | Minia University | Observational | Recruiting | Post-Hepatectomy Liver Failure, Liver Failure, Liver Neoplasms, Carcinoma, Hepatocellular, Liver Metastases... | 1,070 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07727759) |
| July 21, 2026 | NCT07717437 | DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver... | Maastricht University Medical Center | Observational | Recruiting | Liver Cancer, Liver Metastases | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07717437) |
| July 20, 2026 | NCT07714538 | Breath Research Narrow Validation for Gastrointestinal Cancer Detection | Imperial College London | Observational | Recruiting | Oesophageal Squamous Cell Carcinoma, Oesophageal Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic Ductal... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07714538) |
| July 15, 2026 | NCT07704203 | Preoperative 3D Magnetic Resonance Elastography for Predicting Surgical Risk in Patients Undergoing Hepatectomy | Second Affiliated Hospital of Xi'an Jiaotong University | Observational | Not yet recruiting | Hepatic Cancer, Hepatocellular Carcinoma, Intrahepatic Cholangiocellular Carcinoma, Metastatic Hepatocellular Carcinoma | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704203) |
| June 9, 2026 | NCT07636148 | Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance | Sponsor not shown (see the record) | Observational | Recruiting | Liver Cancer (Primary and Metastatic), Lung Cancer (Diagnosis), Bone Cancer Metastatic, Bone Cancer Tumor, Kidney... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07636148) |
| May 22, 2026 | NCT07602504 | China Metastatic Liver Cancer Clinical Registry Cohort Database | Anhui Provincial Hospital | Observational | Recruiting | Liver Metastases, Metastases to Liver, Liver Cancer, Neoplasms, Liver Diseases, Colorectal Cancer Metastatic | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07602504) |
| May 22, 2026 | NCT07601464 | Evaluation of Tissue and Circulating microRNA Profiles in Patients With Hepatocellular Carcinoma Subjected to Thermal Ablation | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | Hepatocarcinoma | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07601464) |
| May 14, 2026 | NCT07587216 | Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment | Tongji Hospital | Observational | Recruiting | Liver Cancer (Primary and Metastatic) | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07587216) |
| May 12, 2026 | NCT07581730 | A Subharmonic-Aided Pressure Estimate Technology for Prediction of Response to Systemic Therapy in Gastric Cancer Liver Metastases | The First Hospital of Jilin University | Observational | Not yet recruiting | Liver Neoplasms, Gastric Cancer (GC), Gastric Cancer Metastatic to Liver | 107 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07581730) |
| April 29, 2026 | NCT07556835 | Outcomes After Liver and Biliary Resection at a High-Volume Center | Azienda USL Toscana Centro | Observational | Not yet recruiting | Liver Neoplasms, Hepatobiliary Diseases, Cholangiocarcinoma, Hepatocellular Carcinoma, Liver Metastases From Colorectal... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07556835) |
| March 16, 2026 | NCT07473687 | Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room | Taipei Veterans General Hospital, Taiwan | Observational | Recruiting | Cholecystitis, Liver Neoplasms, Cholelithiasis, Inguinal Hernia | 315 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07473687) |
| March 3, 2026 | NCT07445412 | Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | Liver Tumours, Liver Cancer (Primary and Metastatic), Liver Resection, Liver Hypertrophy | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07445412) |
| February 17, 2026 | NCT07414433 | Validation of Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma | University of Belgrade | Observational | Not yet recruiting | Hepatocellular Carcinoma (HCC), Liver Neoplasms | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07414433) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Tongji Hospital | 4 |
| Imperial College London | 3 |
| Anhui Provincial Hospital | 3 |
| West China Hospital | 3 |
| Sun Yat-sen University | 3 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 2 |
| National Cancer Institute (NCI) | 2 |
| University of Belgrade | 2 |
| Assiut University | 2 |
| City of Hope Medical Center | 2 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
| University of Sydney | 2 |
| University of Missouri-Columbia | 2 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2 |
| Taipei Veterans General Hospital, Taiwan | 1 |
| Zhongshan People's Hospital, Guangdong, China | 1 |
| Affiliated Hospital of Chengde Medical University | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
| Western University, Canada | 1 |
| Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 1 |
| Ankara University | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Federation Francophone de Cancerologie Digestive | 1 |
| Centre Hospitalier Universitaire Dijon | 1 |
| Second Affiliated Hospital of Xi'an Jiaotong University | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 25 |
| United States | 23 |
| Italy | 8 |
| France | 7 |
| Canada | 6 |
| United Kingdom | 5 |
| Netherlands | 5 |
| South Korea | 4 |
| Australia | 4 |
| Spain | 3 |
| Germany | 3 |
| Belgium | 3 |
| Serbia | 2 |
| Egypt | 2 |
| Taiwan | 1 |
| Turkey (Türkiye) | 1 |
| Vietnam | 1 |
| Austria | 1 |
| New Zealand | 1 |
| Norway | 1 |
| Sweden | 1 |
| Switzerland | 1 |
| Puerto Rico | 1 |
| Japan | 1 |
| Greece | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Coffee shops in the United States](https://specstream.ai/data/businesses/coffee-shops/united-states)
- [Comfort food restaurants in the United States](https://specstream.ai/data/businesses/comfort-food-restaurants/united-states)
- [Computer hardware companies in the United States](https://specstream.ai/data/businesses/computer-hardware-companies/united-states)
- [Construction management firms in the United States](https://specstream.ai/data/businesses/construction-management-firms/united-states)
- [Cosmetic dentistry practices in the United States](https://specstream.ai/data/businesses/cosmetic-dentistry-practices/united-states)
- [Courier and delivery companies in the United States](https://specstream.ai/data/businesses/courier-and-delivery-companies/united-states)
